Dynavax Technologies Corp (DVAX)
11.68
+0.31
(+2.73%)
USD |
NASDAQ |
May 01, 16:00
11.66
-0.02
(-0.17%)
After-Hours: 20:00
Dynavax Technologies 1 Year Total Returns (Daily): 11.03% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 11.03% |
April 30, 2024 | 9.22% |
April 29, 2024 | 8.93% |
April 26, 2024 | 6.26% |
April 25, 2024 | 4.10% |
April 24, 2024 | 4.39% |
April 23, 2024 | 6.72% |
April 22, 2024 | 7.44% |
April 19, 2024 | 7.96% |
April 18, 2024 | 2.72% |
April 17, 2024 | 1.60% |
April 16, 2024 | 3.33% |
April 15, 2024 | 5.13% |
April 12, 2024 | 10.65% |
April 11, 2024 | 11.62% |
April 10, 2024 | 12.95% |
April 09, 2024 | 15.13% |
April 08, 2024 | 15.42% |
April 05, 2024 | 20.14% |
April 04, 2024 | 22.64% |
April 03, 2024 | 23.01% |
April 02, 2024 | 25.48% |
April 01, 2024 | 28.24% |
March 28, 2024 | 27.15% |
March 27, 2024 | 24.72% |
Date | Value |
---|---|
March 26, 2024 | 25.46% |
March 25, 2024 | 26.77% |
March 22, 2024 | 27.75% |
March 21, 2024 | 22.09% |
March 20, 2024 | 22.59% |
March 19, 2024 | 27.33% |
March 18, 2024 | 23.94% |
March 15, 2024 | 23.59% |
March 14, 2024 | 20.80% |
March 13, 2024 | 24.69% |
March 12, 2024 | 29.91% |
March 11, 2024 | 33.30% |
March 08, 2024 | 31.93% |
March 07, 2024 | 27.44% |
March 06, 2024 | 24.20% |
March 05, 2024 | 20.40% |
March 04, 2024 | 22.03% |
March 01, 2024 | 25.22% |
February 29, 2024 | 23.01% |
February 28, 2024 | 25.73% |
February 27, 2024 | 25.39% |
February 26, 2024 | 26.83% |
February 23, 2024 | 18.38% |
February 22, 2024 | 14.13% |
February 21, 2024 | 16.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.00%
Minimum
Jul 26 2019
451.2%
Maximum
Nov 01 2021
28.41%
Average
7.39%
Median
Nov 14 2023
1 Year Total Returns (Daily) Benchmarks
Supernus Pharmaceuticals Inc | -18.65% |
Esperion Therapeutics Inc | 43.66% |
Deciphera Pharmaceuticals Inc | 75.26% |
Ligand Pharmaceuticals Inc | -6.86% |
Pacira BioSciences Inc | -42.17% |